Himaja Ambati 个人学术档案

2022202320242 5 10

开放获取的出版物数量

0 篇文章

1 篇文章

可查看的文章

无法查看的文章

根据资助方的强制性开放获取政策

Balaram GhoshAssistant Professor在 hyderabad.bits-pilani.ac.in 的电子邮件经过验证
Swati BiswasProfessor在 hyderabad.bits-pilani.ac.in 的电子邮件经过验证
Dr. N. ShankaraiahAssociate Professor在 niperhyd.ac.in 的电子邮件经过验证
ROUTHOLLA GANESH .Research scholar在 hyderabad.bits-pilani.ac.in 的电子邮件经过验证
MILAN PAUL .Postdoctoral fellow at Centre of Nanomedicine, Wilmer eye institute, John Hopkins University在 jh.edu 的电子邮件经过验证
Sravani PulyaScientist I在 hyderabad.bits-pilani.ac.in 的电子邮件经过验证
Aparajita GhoshBITS-Pilani, Hyderabad Campus在 hyderabad.bits-pilani.ac.in 的电子邮件经过验证
Kritika LaxmikeshavNational Institute of Pharmaceutical Education and Research, NIPER Hyderabad

Himaja Ambati

BITS Pilani hyderabad campus

在 hyderabad.bits-pilani.ac.in 的电子邮件经过验证


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
Exploration of benzimidazoles as potential microtubule modulators: An insight in the synthetic and therapeutic evolution K Laxmikeshav, A Himaja, N Shankaraiah Journal of Molecular Structure 1253, 132251, 2022	10	2022
Selective HDAC3 inhibitors with potent in vivo Antitumor Efficacy against Triple-negative breast Cancer S Pulya, A Himaja, M Paul, N Adhikari, S Banerjee, G Routholla, S Biswas, ... Journal of Medicinal Chemistry 66 (17), 12033-12058, 2023	7	2023
Advances in the Delivery and Development of Epigenetic Therapeutics for the Treatment of Cancer A Ghosh, A Himaja, S Biswas, O Kulkarni, B Ghosh Molecular Pharmaceutics 20 (12), 5981-6009, 2023	1	2023
Derivatives of D (-) glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-I: Synthesis, biological screening and in … S Das, S Mondal, T Patel, A Himaja, N Adhikari, S Banerjee, SK Baidya, ... European Journal of Medicinal Chemistry, 116563, 2024		2024
Conjugated Nanoparticles for Biotechnology and Bio-Analysis A Ghosh, A Himaja, S Biswas, O Kulkarni, B Ghosh Nanobiotechnology, 277-299, 2024		2024

系统目前无法执行此操作，请稍后再试。

文章 1–5

每年引用数